To examine temporal trends in emergency departments (EDs) visits for bronchiolitis among US children between 2006 and 2010.
Serial, cross-sectional analysis of the Nationwide Emergency Department Sample, a nationally representative sample of ED patients. We used International Classification of Diseases, Ninth Revision, Clinical Modification code 466.1 to identify children <2 years of age with bronchiolitis. Primary outcome measures were rate of bronchiolitis ED visits, hospital admission rate and ED charges.
Between 2006 and 2010, weighted national discharge data included 1,435,110 ED visits with bronchiolitis. There was a modest increase in the rate of bronchiolitis ED visits, from 35.6 to 36.3 per 1000 person-years (2% increase; P trend = 0.008), due to increases in the ED visit rate among children from 12 months to 23 months (24% increase;P trend < 0.001). By contrast, there was a significant decline in the ED visit rate among infants (4% decrease; P trend < 0.001). Although unadjusted admission rate did not change between 2006 and 2010 (26% in both years), admission rate declined significantly after adjusting for potential patient- and ED-level confounders (adjusted odds ratio for comparison of 2010 with 2006, 0.84; 95% confidence interval: 0.76–0.93; P < 0.001). Nationwide ED charges for bronchiolitis increased from $337 million to $389 million (16% increase; P trend < 0.001), adjusted for inflation. This increase was driven by a rise in geometric mean of ED charges per case from $887 to $1059 (19% increase; P trend < 0.001).
Between 2006 and 2010, we found a divergent temporal trend in the rate of bronchiolitis ED visits by age group. Despite a significant increase in associated ED charges, ED-associated hospital admission rates for bronchiolitis significantly decreased over this same period.
Supplemental Digital Content is available in the text.
From the *Massachusetts General Hospital; †Harvard Medical School; ‡Beth Israel Deaconess Medical Center, Boston, MA; §Center for Clinical Epidemiology of St. Luke’s Life Science Institute, Tokyo, Japan; and ¶Boston Children’s Hospital, Boston, MA.
Accepted for publication July 19, 2013.
K.H. was supported, in part, by Eleanor and Miles Shore Fellowship Program (Boston, MA). Y.T. was supported, in part, by St. Luke’s Life Science Institute (Tokyo). J.M.M. and C.A.C were supported, in part, by NIH U01 AI-87881 (Bethesda, MD). The funding organizations had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the article. The authors have no other funding or conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Kohei Hasegawa, MD, MPH, Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, 326 Cambridge Street, Suite 410, Boston, MA 02114. E-mail: firstname.lastname@example.org.